under trademark “Wuttisak Clinic” the Company has change the business strategy for appropriate with the business environment by closed 7 departments which have accumulate loss in July 2019 and decreased

profit (loss) 267 114 153 134.0% EPS (THB) 0.316 0.135 0.181 134.0% Change Major Developments in 4Q17 The SEC approved the issuance and offering for sale of 409.4 million DREIT trust units as listed

summarized as follows: Consolidated FS Quarter 1/2019 Quarter 1/2020 Change MB. % MB. % MB. % Revenue from contracts with customers 1,943.6 70.9% 1,714.0 64.3% -229.6 -11.8% Interest income from loans from the

Company’s operating performance in 2017 and 2016 is shown in the following table: FY2017 FY2016 % Change FY2015 % Change [Amount in Baht Million] Y-o-Y Y-o-Y [2017 VS. 2016] [2016 VS. 2015] Sales Revenue

exchange rate of receivable under finance lease agreement, gain(loss) on forward contracts, insurance claim and gain from business acquisition. Change QoQ Consolidated financial statements Change YoY 2

income has not arisen and, according to the action plan, the commencement of the income recognition in this part will start within quarter 1/2017. After Blue Finix’s success in August 2017, the official

arisen and, according to the action plan, the commencement of the income recognition in this part will start within quarter 1/2017. After Blue Finix’s success in August 2017, the official press conference

earnings translation. US$ 155M lower EBITDA in LTM3Q19 and US$ 22M in 3Q19 due to unplanned shutdowns, catalysts change planned shurdown in EOEG assets in USA and one line conversion from PTA to IPA in USA

% -0.4% 12.8% 12.6% 0.2% Net profit margin attributable to the owners of the parent 12.4% 12.5% -0.1% 12.7% 12.4% 0.3% Key Change in Segment Grouping In 2019, the Company has changed reportable segments

will be stared in 1Q2020 and it takes one year from start to completion (the extension is included) 2. Involved Parties Contractor: the contractor will be selected and signing the contract after